{"abstracts-retrieval-response": {"item": {"ait:process-info": {"ait:status": {"@state": "update", "@type": "core", "@stage": "S300"}, "ait:date-delivered": {"@day": "27", "@year": "2019", "@timestamp": "2019-10-27T23:12:52.000052-04:00", "@month": "10"}, "ait:date-sort": {"@day": "18", "@year": "2016", "@month": "05"}}, "bibrecord": {"head": {"author-group": {"affiliation": {"country": "Thailand", "@afid": "60028190", "@country": "tha", "city": "Bangkok", "organization": [{"$": "Department of Ophthalmology"}, {"$": "Faculty of Medicine"}, {"$": "Chulalongkorn University"}], "affiliation-id": {"@afid": "60028190", "@dptid": "104425658"}, "@dptid": "104425658"}, "author": [{"ce:given-name": "Sittikorn", "preferred-name": {"ce:given-name": "Sittikorn", "ce:initials": "S.", "ce:surname": "Laojaroenwanit", "ce:indexed-name": "Laojaroenwanit S."}, "@seq": "1", "ce:initials": "S.", "@_fa": "true", "@type": "auth", "ce:surname": "Laojaroenwanit", "@auid": "57189643426", "ce:indexed-name": "Laojaroenwanit S."}, {"ce:given-name": "Vimontip", "preferred-name": {"ce:given-name": "Vimontip", "ce:initials": "V.", "ce:surname": "Layanun", "ce:indexed-name": "Layanun V."}, "@seq": "2", "ce:initials": "V.", "@_fa": "true", "@type": "auth", "ce:surname": "Layanun", "@auid": "57189640415", "ce:indexed-name": "Layanun V."}, {"ce:given-name": "Pokpong", "preferred-name": {"ce:given-name": "Pokpong", "ce:initials": "P.", "ce:surname": "Praneeprachachon", "ce:indexed-name": "Praneeprachachon P."}, "@seq": "3", "ce:initials": "P.", "@_fa": "true", "@type": "auth", "ce:surname": "Praneeprachachon", "@auid": "56401134800", "ce:indexed-name": "Praneeprachachon P."}, {"ce:given-name": "Parnchat", "preferred-name": {"ce:given-name": "Parnchat", "ce:initials": "P.", "ce:surname": "Pukrushpan", "ce:indexed-name": "Pukrushpan P."}, "@seq": "4", "ce:initials": "P.", "@_fa": "true", "@type": "auth", "ce:surname": "Pukrushpan", "@auid": "12799090500", "ce:indexed-name": "Pukrushpan P."}]}, "citation-title": "Time of maximum cycloplegia after instillation of cyclopentolate 1% in children with brown irises", "abstracts": "\u00a9 2016 Laojaroenwanit et al.Purpose: We aimed to 1) determine the time of maximum cycloplegia after instillation of cyclopentolate 1% in children with brown irises, 2) evaluate the correlation between the pupillary reaction and time of maximum cycloplegia, and 3) identify any side effects of the medication. Patients and methods: This was a prospective analytical study involving children aged 5 to 14 years who were attending refraction clinic. Cyclopentolate 1% was instilled three times at 10-minute intervals. The spherical equivalent, pupillary reaction, and pupillary diameter were recorded before the first drop and nine times after the last drop at 10-minute intervals. Side effects were assessed. Time of maximum cycloplegia was determined from the time point at which the 95% confidence interval of the differences between the mean spherical equivalent at each point and its final value at 110 minutes was reached and remained within the equivalence limit (\u00b10.25 D). Results: Sixty children were enrolled in this study. Their mean age was 9.8 years (range: 5-14 years). Time of maximum cycloplegia was reached at 30 minutes after the first instillation of cyclopentolate. A poor correlation was observed between the pupillary reaction and the time of maximum cycloplegia (r=-0.07). The mean pupillary diameter at 30 minutes was 3.7\u00b11.3 mm, and further dilation occurred thereafter. No side effects were observed. Conclusion: In most children, maximum cycloplegia was reached 30 minutes after the first instillation of cyclopentolate. The absence of a pupillary reaction should not be used as an indicator of maximum cycloplegia.", "correspondence": {"affiliation": {"country": "Thailand", "address-part": "1873 Rama 4 Road, Pathumwan", "postal-code": "10330", "@country": "tha", "city": "Bangkok", "organization": [{"$": "Pediatric Ophthalmology and Strabismus Division"}, {"$": "Department of Ophthalmology"}, {"$": "Faculty of Medicine"}, {"$": "Chulalongkorn University"}]}, "person": {"ce:given-name": "Parnchat", "ce:initials": "P.", "ce:surname": "Pukrushpan", "ce:indexed-name": "Pukrushpan P."}}, "citation-info": {"author-keywords": {"author-keyword": [{"$": "Brown irises", "@xml:lang": "eng"}, {"$": "Cyclopentolate", "@xml:lang": "eng"}, {"$": "Cycloplegia", "@xml:lang": "eng"}, {"$": "Cycloplegic refraction", "@xml:lang": "eng"}, {"$": "Refraction", "@xml:lang": "eng"}]}, "citation-type": {"@code": "ar"}, "citation-language": {"@language": "English", "@xml:lang": "eng"}, "abstract-language": {"@language": "English", "@xml:lang": "eng"}}, "source": {"sourcetitle-abbrev": "Clin. Ophthalmol.", "website": {"ce:e-address": {"$": "https://www.dovepress.com/getfile.php?fileID=30438", "@type": "email"}}, "@country": "nzl", "translated-sourcetitle": {"$": "Clinical Ophthalmology", "@xml:lang": "eng"}, "issn": [{"$": "11775483", "@type": "electronic"}, {"$": "11775467", "@type": "print"}], "volisspag": {"voliss": {"@volume": "10"}, "pagerange": {"@first": "897", "@last": "902"}}, "@type": "j", "publicationyear": {"@first": "2016"}, "publisher": {"affiliation": {"address-part": "PO Box 300-008, Albany", "postal-code": "0752", "@country": "nzl", "city": "44 Corinthian Drive, Albany,Auckland"}, "publishername": "Dove Medical Press Ltd", "ce:e-address": {"$": "angela@dovepress.com", "@type": "email"}}, "sourcetitle": "Clinical Ophthalmology", "@srcid": "19700175081", "publicationdate": {"month": "05", "year": "2016", "date-text": {"@xfab-added": "true", "$": "18 May 2016"}, "day": "18"}}, "enhancement": {"classificationgroup": {"classifications": [{"@type": "EMCLASS", "classification": [{"classification-code": "12", "classification-description": "Ophthalmology"}, {"classification-code": "37", "classification-description": "Drug Literature Index"}, {"classification-code": "38", "classification-description": "Adverse Reactions Titles"}, {"classification-code": "7", "classification-description": "Pediatrics and Pediatric Surgery"}]}, {"@type": "ASJC", "classification": "2731"}, {"@type": "SUBJABBR", "classification": "MEDI"}]}, "chemicalgroup": {"chemicals": {"@source": "esbd", "chemical": {"cas-registry-number": [{"$": "512-15-2"}, {"$": "5870-29-1"}], "chemical-name": "cyclopentolate"}}}}}, "item-info": {"copyright": {"$": "Copyright 2017 Elsevier B.V., All rights reserved.", "@type": "Elsevier"}, "dbcollection": [{"$": "EMBASE"}, {"$": "REAXYSCAR"}, {"$": "RMC"}, {"$": "SCOPUS"}, {"$": "Scopusbase"}], "history": {"date-created": {"@day": "21", "@year": "2016", "@timestamp": "BST 10:40:59", "@month": "06"}}, "itemidlist": {"itemid": [{"$": "610732377", "@idtype": "PUI"}, {"$": "651356961", "@idtype": "CAR-ID"}, {"$": "20160443978", "@idtype": "EMBASE"}, {"$": "20161359484", "@idtype": "REAXYSCAR"}, {"$": "2016176062", "@idtype": "RMC"}, {"$": "84973624955", "@idtype": "SCP"}, {"$": "84973624955", "@idtype": "SGR"}], "ce:doi": "10.2147/OPTH.S102611"}}, "tail": {"bibliography": {"@refcount": "11", "reference": [{"ref-fulltext": "Ebri A, Kuper H, Wedner S. Cost-effectiveness of cycloplegic agents: results of a randomized controlled trial in Nigerian children. Invest Ophthalmol Vis Sci. 2007;48(3):1025-1031.", "@id": "1", "ref-info": {"ref-publicationyear": {"@first": "2007"}, "ref-title": {"ref-titletext": "Cost-effectiveness of cycloplegic agents: Results of a randomized controlled trial in Nigerian children"}, "refd-itemidlist": {"itemid": {"$": "34047248215", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "48", "@issue": "3"}, "pagerange": {"@first": "1025", "@last": "1031"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "A.", "@_fa": "true", "ce:surname": "Ebri", "ce:indexed-name": "Ebri A."}, {"@seq": "2", "ce:initials": "H.", "@_fa": "true", "ce:surname": "Kuper", "ce:indexed-name": "Kuper H."}, {"@seq": "3", "ce:initials": "S.", "@_fa": "true", "ce:surname": "Wedner", "ce:indexed-name": "Wedner S."}]}, "ref-sourcetitle": "Invest Ophthalmol Vis Sci"}}, {"ref-fulltext": "Stolzar IH. A new group of cycloplegic drugs. Am J Ophthalmol. 1953;36(1):110-112.", "@id": "2", "ref-info": {"ref-publicationyear": {"@first": "1953"}, "ref-title": {"ref-titletext": "A new group of cycloplegic drugs"}, "refd-itemidlist": {"itemid": {"$": "0004937007", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "36", "@issue": "1"}, "pagerange": {"@first": "110", "@last": "112"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "I.H.", "@_fa": "true", "ce:surname": "Stolzar", "ce:indexed-name": "Stolzar I.H."}]}, "ref-sourcetitle": "Am J Ophthalmol"}}, {"ref-fulltext": "Lovasik JV. Pharmacokinetics of topically applied cyclopentolate HCl and tropicamide. Am J Optom Physiol Opt. 1986;63(10):787-803.", "@id": "3", "ref-info": {"ref-publicationyear": {"@first": "1986"}, "ref-title": {"ref-titletext": "Pharmacokinetics of topically applied cyclopentolate HCl and tropicamide"}, "refd-itemidlist": {"itemid": {"$": "0022976356", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "63", "@issue": "10"}, "pagerange": {"@first": "787", "@last": "803"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "J.V.", "@_fa": "true", "ce:surname": "Lovasik", "ce:indexed-name": "Lovasik J.V."}]}, "ref-sourcetitle": "Am J Optom Physiol Opt"}}, {"ref-fulltext": "Miranda MN. Residual accommodation. A comparison between cyclopentolate 1 per cent and a combination of cyclopentolate 1 per cent and tropicamaide 1 per cent. Arch Ophthalmol. 1972;87(5):515-517.", "@id": "4", "ref-info": {"ref-publicationyear": {"@first": "1972"}, "ref-title": {"ref-titletext": "Residual accommodation. A comparison between cyclopentolate 1 per cent and a combination of cyclopentolate 1 per cent and tropicamaide 1 per cent"}, "refd-itemidlist": {"itemid": {"$": "0015333110", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "87", "@issue": "5"}, "pagerange": {"@first": "515", "@last": "517"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "M.N.", "@_fa": "true", "ce:surname": "Miranda", "ce:indexed-name": "Miranda M.N."}]}, "ref-sourcetitle": "Arch Ophthalmol"}}, {"ref-fulltext": "Egashira SM, Kish LL, Twelker JD, et al. Comparison of cyclopentolate versus tropicamide cycloplegia in children. Optom Vis Sci. 1993;70(12):1019-1026.", "@id": "5", "ref-info": {"ref-publicationyear": {"@first": "1993"}, "ref-title": {"ref-titletext": "Comparison of cyclopentolate versus tropicamide cycloplegia in children"}, "refd-itemidlist": {"itemid": {"$": "0027770096", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "70", "@issue": "12"}, "pagerange": {"@first": "1019", "@last": "1026"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "S.M.", "@_fa": "true", "ce:surname": "Egashira", "ce:indexed-name": "Egashira S.M."}, {"@seq": "2", "ce:initials": "L.L.", "@_fa": "true", "ce:surname": "Kish", "ce:indexed-name": "Kish L.L."}, {"@seq": "3", "ce:initials": "J.D.", "@_fa": "true", "ce:surname": "Twelker", "ce:indexed-name": "Twelker J.D."}], "et-al": null}, "ref-sourcetitle": "Optom Vis Sci"}}, {"ref-fulltext": "Manny RE, Fern KD, Zervas HJ, et al. 1% Cyclopentolate hydrochloride: another look at the time course of cycloplegia using an objective measure of the accommodative response. Optom Vis Sci. 1993;70(8):651-665.", "@id": "6", "ref-info": {"ref-publicationyear": {"@first": "1993"}, "ref-title": {"ref-titletext": "1% Cyclopentolate hydrochloride: Another look at the time course of cycloplegia using an objective measure of the accommodative response"}, "refd-itemidlist": {"itemid": {"$": "0027324166", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "70", "@issue": "8"}, "pagerange": {"@first": "651", "@last": "665"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "R.E.", "@_fa": "true", "ce:surname": "Manny", "ce:indexed-name": "Manny R.E."}, {"@seq": "2", "ce:initials": "K.D.", "@_fa": "true", "ce:surname": "Fern", "ce:indexed-name": "Fern K.D."}, {"@seq": "3", "ce:initials": "H.J.", "@_fa": "true", "ce:surname": "Zervas", "ce:indexed-name": "Zervas H.J."}], "et-al": null}, "ref-sourcetitle": "Optom Vis Sci"}}, {"ref-fulltext": "Lin LL, Shih YF, Hsiao CH, et al. The cycloplegic effects of cyclopentolate and tropicamide on myopic children. J Ocul Pharmacol Ther. 1998;14(4):331-335.", "@id": "7", "ref-info": {"ref-publicationyear": {"@first": "1998"}, "ref-title": {"ref-titletext": "The cycloplegic effects of cyclopentolate and tropicamide on myopic children"}, "refd-itemidlist": {"itemid": {"$": "0031821996", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "14", "@issue": "4"}, "pagerange": {"@first": "331", "@last": "335"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "L.L.", "@_fa": "true", "ce:surname": "Lin", "ce:indexed-name": "Lin L.L."}, {"@seq": "2", "ce:initials": "Y.F.", "@_fa": "true", "ce:surname": "Shih", "ce:indexed-name": "Shih Y.F."}, {"@seq": "3", "ce:initials": "C.H.", "@_fa": "true", "ce:surname": "Hsiao", "ce:indexed-name": "Hsiao C.H."}], "et-al": null}, "ref-sourcetitle": "J Ocul Pharmacol Ther"}}, {"ref-fulltext": "Wang X, Ma L, Wang L. Research of cyclopentolate 1% on the effect of cycloplegia for Chinese hyperopic children. Zhonghua Yan Ke Za Zhi. 2011;14(4):989-994.", "@id": "8", "ref-info": {"ref-publicationyear": {"@first": "2011"}, "ref-title": {"ref-titletext": "Research of cyclopentolate 1% on the effect of cycloplegia for Chinese hyperopic children"}, "refd-itemidlist": {"itemid": {"$": "84863532625", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "14", "@issue": "4"}, "pagerange": {"@first": "989", "@last": "994"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "X.", "@_fa": "true", "ce:surname": "Wang", "ce:indexed-name": "Wang X."}, {"@seq": "2", "ce:initials": "L.", "@_fa": "true", "ce:surname": "Ma", "ce:indexed-name": "Ma L."}, {"@seq": "3", "ce:initials": "L.", "@_fa": "true", "ce:surname": "Wang", "ce:indexed-name": "Wang L."}]}, "ref-sourcetitle": "Zhonghua Yan Ke Za Zhi"}}, {"ref-fulltext": "Bagheri A, Givrad S, Yazdani S, et al. Optimal dosage of cyclopentolate 1% for complete cycloplegia: a randomized clinical trial. Eur J Ophthalmol. 2007;17(3):294-300.", "@id": "9", "ref-info": {"ref-publicationyear": {"@first": "2007"}, "ref-title": {"ref-titletext": "Optimal dosage of cyclopentolate 1% for complete cycloplegia: A randomized clinical trial"}, "refd-itemidlist": {"itemid": {"$": "34447118196", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "17", "@issue": "3"}, "pagerange": {"@first": "294", "@last": "300"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "A.", "@_fa": "true", "ce:surname": "Bagheri", "ce:indexed-name": "Bagheri A."}, {"@seq": "2", "ce:initials": "S.", "@_fa": "true", "ce:surname": "Givrad", "ce:indexed-name": "Givrad S."}, {"@seq": "3", "ce:initials": "S.", "@_fa": "true", "ce:surname": "Yazdani", "ce:indexed-name": "Yazdani S."}], "et-al": null}, "ref-sourcetitle": "Eur J Ophthalmol"}}, {"ref-fulltext": "Mohan K, Sharma A. Optimal dosage of cyclopentolate 1% for cycloplegic refraction in hypermetropes with brown irides. Indian J Ophthalmol. 2011;59(6):514-516.", "@id": "10", "ref-info": {"ref-publicationyear": {"@first": "2011"}, "ref-title": {"ref-titletext": "Optimal dosage of cyclopentolate 1% for cycloplegic refraction in hypermetropes with brown irides"}, "refd-itemidlist": {"itemid": {"$": "80155149882", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "59", "@issue": "6"}, "pagerange": {"@first": "514", "@last": "516"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "K.", "@_fa": "true", "ce:surname": "Mohan", "ce:indexed-name": "Mohan K."}, {"@seq": "2", "ce:initials": "A.", "@_fa": "true", "ce:surname": "Sharma", "ce:indexed-name": "Sharma A."}]}, "ref-sourcetitle": "Indian J Ophthalmol"}}, {"ref-fulltext": "Fan DS, Rao SK, Ng JS, et al. Comparative study on the safety and efficacy of different cycloplegic agents in children with darkly pigmented irides. Clin Experiment Ophthalmol. 2004;32(5):462-467.", "@id": "11", "ref-info": {"ref-publicationyear": {"@first": "2004"}, "ref-title": {"ref-titletext": "Comparative study on the safety and efficacy of different cycloplegic agents in children with darkly pigmented irides"}, "refd-itemidlist": {"itemid": {"$": "8644220679", "@idtype": "SGR"}}, "ref-volisspag": {"voliss": {"@volume": "32", "@issue": "5"}, "pagerange": {"@first": "462", "@last": "467"}}, "ref-authors": {"author": [{"@seq": "1", "ce:initials": "D.S.", "@_fa": "true", "ce:surname": "Fan", "ce:indexed-name": "Fan D.S."}, {"@seq": "2", "ce:initials": "S.K.", "@_fa": "true", "ce:surname": "Rao", "ce:indexed-name": "Rao S.K."}, {"@seq": "3", "ce:initials": "J.S.", "@_fa": "true", "ce:surname": "Ng", "ce:indexed-name": "Ng J.S."}], "et-al": null}, "ref-sourcetitle": "Clin Experiment Ophthalmol"}}]}}}}, "affiliation": {"affiliation-city": "Bangkok", "@id": "60028190", "affilname": "Chulalongkorn University", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190", "affiliation-country": "Thailand"}, "coredata": {"srctype": "j", "eid": "2-s2.0-84973624955", "dc:description": "Purpose: We aimed to 1) determine the time of maximum cycloplegia after instillation of cyclopentolate 1% in children with brown irises, 2) evaluate the correlation between the pupillary reaction and time of maximum cycloplegia, and 3) identify any side effects of the medication. Patients and methods: This was a prospective analytical study involving children aged 5 to 14 years who were attending refraction clinic. Cyclopentolate 1% was instilled three times at 10-minute intervals. The spherical equivalent, pupillary reaction, and pupillary diameter were recorded before the first drop and nine times after the last drop at 10-minute intervals. Side effects were assessed. Time of maximum cycloplegia was determined from the time point at which the 95% confidence interval of the differences between the mean spherical equivalent at each point and its final value at 110 minutes was reached and remained within the equivalence limit (\u00b10.25 D). Results: Sixty children were enrolled in this study. Their mean age was 9.8 years (range: 5-14 years). Time of maximum cycloplegia was reached at 30 minutes after the first instillation of cyclopentolate. A poor correlation was observed between the pupillary reaction and the time of maximum cycloplegia (r=-0.07). The mean pupillary diameter at 30 minutes was 3.7\u00b11.3 mm, and further dilation occurred thereafter. No side effects were observed. Conclusion: In most children, maximum cycloplegia was reached 30 minutes after the first instillation of cyclopentolate. The absence of a pupillary reaction should not be used as an indicator of maximum cycloplegia.", "prism:coverDate": "2016-05-18", "prism:aggregationType": "Journal", "prism:url": "https://api.elsevier.com/content/abstract/scopus_id/84973624955", "dc:creator": {"author": [{"ce:given-name": "Sittikorn", "preferred-name": {"ce:given-name": "Sittikorn", "ce:initials": "S.", "ce:surname": "Laojaroenwanit", "ce:indexed-name": "Laojaroenwanit S."}, "@seq": "1", "ce:initials": "S.", "@_fa": "true", "affiliation": {"@id": "60028190", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"}, "ce:surname": "Laojaroenwanit", "@auid": "57189643426", "author-url": "https://api.elsevier.com/content/author/author_id/57189643426", "ce:indexed-name": "Laojaroenwanit S."}]}, "link": [{"@_fa": "true", "@rel": "self", "@href": "https://api.elsevier.com/content/abstract/scopus_id/84973624955"}, {"@_fa": "true", "@rel": "scopus", "@href": "https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84973624955&origin=inward"}, {"@_fa": "true", "@rel": "scopus-citedby", "@href": "https://www.scopus.com/inward/citedby.uri?partnerID=HzOxMe3b&scp=84973624955&origin=inward"}], "source-id": "19700175081", "citedby-count": "17", "prism:volume": "10", "subtype": "ar", "dc:title": "Time of maximum cycloplegia after instillation of cyclopentolate 1% in children with brown irises", "openaccess": "1", "prism:issn": "11775483 11775467", "publishercopyright": "\u00a9 2016 Laojaroenwanit et al.", "subtypeDescription": "Article", "prism:publicationName": "Clinical Ophthalmology", "prism:pageRange": "897-902", "prism:endingPage": "902", "openaccessFlag": "true", "prism:doi": "10.2147/OPTH.S102611", "prism:startingPage": "897", "dc:identifier": "SCOPUS_ID:84973624955", "dc:publisher": "Dove Medical Press LtdPO Box 300-008, Albany44 Corinthian Drive, Albany,Auckland0752angela@dovepress.com"}, "idxterms": null, "language": {"@xml:lang": "eng"}, "authkeywords": {"author-keyword": [{"@_fa": "true", "$": "Brown irises"}, {"@_fa": "true", "$": "Cyclopentolate"}, {"@_fa": "true", "$": "Cycloplegia"}, {"@_fa": "true", "$": "Cycloplegic refraction"}, {"@_fa": "true", "$": "Refraction"}]}, "subject-areas": {"subject-area": [{"@_fa": "true", "$": "Ophthalmology", "@code": "2731", "@abbrev": "MEDI"}]}, "authors": {"author": [{"ce:given-name": "Sittikorn", "preferred-name": {"ce:given-name": "Sittikorn", "ce:initials": "S.", "ce:surname": "Laojaroenwanit", "ce:indexed-name": "Laojaroenwanit S."}, "@seq": "1", "ce:initials": "S.", "@_fa": "true", "affiliation": {"@id": "60028190", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"}, "ce:surname": "Laojaroenwanit", "@auid": "57189643426", "author-url": "https://api.elsevier.com/content/author/author_id/57189643426", "ce:indexed-name": "Laojaroenwanit S."}, {"ce:given-name": "Vimontip", "preferred-name": {"ce:given-name": "Vimontip", "ce:initials": "V.", "ce:surname": "Layanun", "ce:indexed-name": "Layanun V."}, "@seq": "2", "ce:initials": "V.", "@_fa": "true", "affiliation": {"@id": "60028190", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"}, "ce:surname": "Layanun", "@auid": "57189640415", "author-url": "https://api.elsevier.com/content/author/author_id/57189640415", "ce:indexed-name": "Layanun V."}, {"ce:given-name": "Pokpong", "preferred-name": {"ce:given-name": "Pokpong", "ce:initials": "P.", "ce:surname": "Praneeprachachon", "ce:indexed-name": "Praneeprachachon P."}, "@seq": "3", "ce:initials": "P.", "@_fa": "true", "affiliation": {"@id": "60028190", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"}, "ce:surname": "Praneeprachachon", "@auid": "56401134800", "author-url": "https://api.elsevier.com/content/author/author_id/56401134800", "ce:indexed-name": "Praneeprachachon P."}, {"ce:given-name": "Parnchat", "preferred-name": {"ce:given-name": "Parnchat", "ce:initials": "P.", "ce:surname": "Pukrushpan", "ce:indexed-name": "Pukrushpan P."}, "@seq": "4", "ce:initials": "P.", "@_fa": "true", "affiliation": {"@id": "60028190", "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190"}, "ce:surname": "Pukrushpan", "@auid": "12799090500", "author-url": "https://api.elsevier.com/content/author/author_id/12799090500", "ce:indexed-name": "Pukrushpan P."}]}}}